Skip to main content
. 2012 Jun 27;14(4):677–687. doi: 10.1208/s12248-012-9383-0

Table V.

Mitigation of Positive Food Effect via the use of Nanosuspension Formulations in Commercial Products

Product Food effect (% increase AUC) for nanosuspension Food effect (% increase AUC) for original/early formulations
EMEND® 20% (125 mg), 9% (80 mg)a 2.7-fold (100 mg)
TRICOR® 5% (145 mg)a 35% (160 mg)
MEGACE® ES 36% (625 mg) 2-fold (800 mg)
TRIGLIDETM 14% (160 mg)a 35% (160 mg)

AUC area under the plasma concentration curve

aExposures within bioequivalence bounds